Related Experiment Video
Updated: Sep 11, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
NSUN2 promotes osteosarcoma metastasis via stabilizing UBE2S mRNA in an m5C-dependent manner
Yu Chen1, Ranran Sun2, Liwen Liu2
1Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.
Abstract:
5-methylcytosine (m5C) is a prevalent posttranscriptional RNA modification that participates in the initiation and progression of various cancers. NSUN2 is the primary RNA methyltransferase responsible for catalyzing the formation of m5C. However, its regulatory role and potential mechanism in osteosarcoma are still unclear. Here, we demonstrated that the NSUN2 expression was markedly upregulated in osteosarcoma tissues and cell lines. Clinically, increased NSUN2 expression was associated with poor prognosis. Functional studies revealed that NSUN2 significantly promoted metastasis and epithelial-mesenchymal transition (EMT) in osteosarcoma. Mechanistically, integrated analysis based on RNA sequencing and expression correlation identified UBE2S as a downstream target gene of NSUN2, while NSUN2 enhanced the stabilization of UBE2S mRNA in an m5C-dependent manner. More importantly, UBE2S overexpression reversed the inhibition of cell invasion and EMT induced by NSUN2 knockdown. Moreover, UBE2S interacted with and ubiquitinated β-catenin, enhancing its stability and activation. Interestingly, osteosarcoma patients with dual-high expression of NSUN2 and UBE2S exhibited shorter overall survival. In summary, our study revealed that NSUN2 facilitated metastasis by enhancing the UBE2S/β-catenin axis, suggesting a potential therapeutic approach for osteosarcoma.
Insights
NSUN2, an RNA methyltransferase, promotes osteosarcoma metastasis by stabilizing UBE2S mRNA. This NSUN2-UBE2S axis enhances the UBE2S/β-catenin pathway, indicating a potential therapeutic target for osteosarcoma progression.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- 5-methylcytosine (m5C) is a key RNA modification involved in cancer.
- NSUN2 is the main enzyme catalyzing m5C formation.
- The role of NSUN2 in osteosarcoma remains largely unknown.
Purpose of the Study:
- To investigate the role and mechanism of NSUN2 in osteosarcoma.
- To identify downstream targets and pathways regulated by NSUN2.
- To explore the clinical significance of NSUN2 in osteosarcoma.
Main Methods:
- Analysis of NSUN2 expression in osteosarcoma tissues and cell lines.
- Functional assays to assess the impact of NSUN2 on metastasis and EMT.
- RNA sequencing and expression correlation to identify NSUN2 targets.
- Western blotting and ubiquitination assays to study protein interactions.
Main Results:
- NSUN2 expression is upregulated in osteosarcoma and correlates with poor prognosis.
- NSUN2 promotes osteosarcoma cell metastasis and epithelial-mesenchymal transition (EMT).
- UBE2S is a downstream target of NSUN2, with NSUN2 stabilizing UBE2S mRNA via m5C modification.
- UBE2S interacts with and ubiquitinates β-catenin, enhancing its stability and activation.
- Dual-high expression of NSUN2 and UBE2S predicts shorter survival in osteosarcoma patients.
Conclusions:
- NSUN2 promotes osteosarcoma metastasis through the UBE2S/β-catenin signaling pathway.
- Targeting the NSUN2-UBE2S axis may offer a therapeutic strategy for osteosarcoma.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
Nuclear Export of mRNA
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Nucleolus
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation